Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Green Thumb Industries's net current asset value per share for the quarter that ended in Mar. 2026 was $-1.17.
The historical rank and industry rank for Green Thumb Industries's Net Current Asset Value or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Green Thumb Industries was 224.33. The lowest was 14.04. And the median was 29.84.
GTBIF's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.78 * Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
Green Thumb Industries (OTCPK:GTBIF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Green Thumb Industries Net Current Asset Value Related Terms
Green Thumb Industries Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Green Thumb Industries's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Thumb Industries Net Current Asset Value Chart
GTBIF vs ZTS, UTHR: Net Current Asset Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Thumb Industries Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Green Thumb Industries's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $-1.17 mean?
Green Thumb Industries (GTBIF) has a Net Current Asset Value of $-1.17 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Green Thumb Industries and its competitors. Over the past decade, Green Thumb Industries' Net Current Asset Value has ranged from 14.04 to 224.33. According to the industry distribution chart, Green Thumb Industries ranks #999999 out of 611 companies in the Drug Manufacturers industry.
Is Green Thumb Industries' Net Current Asset Value too high?
Green Thumb Industries' current Net Current Asset Value is $-1.17. Over the past 10 years, this metric has ranged from a low of 14.04 to a high of 224.33. Based on the distribution chart, Green Thumb Industries ranks #999999 out of 611 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Green Thumb Industries has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Green Thumb Industries' Net Current Asset Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Green Thumb Industries ranks #999999 out of 611 companies for Net Current Asset Value. This places Green Thumb Industries in the lower half of its industry. The industry median Net Current Asset Value is 5.78. Historically, Green Thumb Industries' own Net Current Asset Value has ranged from 14.04 to 224.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 5.78, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Green Thumb Industries and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 5.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Thumb Industries's current Net Current Asset Value is $-1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Thumb Industries stock overvalued right now?
Based on GuruFocus' analysis, Green Thumb Industries (GTBIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.91, compared to a current price of $7.16 — trading 19.6% below its estimated fair value. The current Net Current Asset Value is $-1.17. Green Thumb Industries' overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Green Thumb Industries (GTBIF), the current Net Current Asset Value is $-1.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Thumb Industries (GTBIF) Overvalued in 2026?
Based on GuruFocus' analysis, Green Thumb Industries stock appears to be undervalued.
The current stock price of $7.16 is trading 19.6% below its estimated GF Value™ of $8.91.
GuruFocus considers Green Thumb Industries to be Modestly Undervalued.
Key valuation signals for GTBIF:
Net Current Asset Value: $-1.17
GF Value™: $8.91 vs. price of $7.16 (19.6% below fair value)
No single metric tells the full story. See the GTBIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited-license states with large populations, and it does not currently export into the global medical market due to the USA federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, Incredibles, and RYTHM.
84GF Score
Get the complete analysis for GTBIF
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GTBIF has been successfully added to your 
